DE MINICIS, SAMUELE
 Distribuzione geografica
Continente #
NA - Nord America 1.642
EU - Europa 849
AS - Asia 236
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.740
Nazione #
US - Stati Uniti d'America 1.638
UA - Ucraina 214
IT - Italia 168
SE - Svezia 112
IE - Irlanda 103
DE - Germania 90
DK - Danimarca 82
CN - Cina 69
SG - Singapore 57
FI - Finlandia 45
TR - Turchia 45
KR - Corea 42
GB - Regno Unito 31
VN - Vietnam 8
CI - Costa d'Avorio 7
CA - Canada 4
EU - Europa 4
IN - India 4
IR - Iran 4
JP - Giappone 3
BE - Belgio 2
EG - Egitto 2
PK - Pakistan 2
RS - Serbia 2
TW - Taiwan 2
Totale 2.740
Città #
Jacksonville 218
Chandler 216
Fairfield 176
Dublin 103
Ashburn 97
Woodbridge 88
Wilmington 86
Boardman 76
Des Moines 76
Houston 64
New York 57
Seattle 53
Centro 49
Cambridge 48
San Mateo 44
Lawrence 42
Princeton 42
Turin 41
Ann Arbor 28
San Diego 13
Beijing 12
London 12
Wuhan 11
Marche 10
Singapore 10
Dong Ket 8
Abidjan 7
Los Angeles 7
Washington 7
Guangzhou 6
Shanghai 6
Helsinki 5
Izmir 4
Jiaxing 4
Milan 4
New Bedfont 4
Falerone 3
Kilburn 3
Pune 3
Rome 3
Senigallia 3
Wuxi 3
Belgrade 2
Brussels 2
Cairo 2
Civitanova Marche 2
Jinhua 2
Norwalk 2
Ottawa 2
Taipei 2
Venice 2
Acton 1
Ascoli Piceno 1
Aversa 1
Bangalore 1
Baricella 1
Clifton 1
Edinburgh 1
Fabriano 1
Falkenstein 1
Fayetteville 1
Florence 1
Genova 1
Hangzhou 1
Hanover 1
Islamabad 1
Kyiv 1
Kyoto 1
Liverpool 1
Miami Beach 1
Oakville 1
Pakistan 1
Porto 1
Reggio Nell'emilia 1
Santa Clara 1
Seoul 1
Suzhou 1
Torino 1
Totale 1.797
Nome #
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 98
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 93
Clinical implications of novel aspects of biliary pathophysiology. 92
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 91
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 90
From the metabolic syndrome to NAFLD or vice versa? 89
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 85
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 77
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 76
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 76
HIV protein gp120 and chemokines receptor for liver fibrosis. 75
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 75
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 72
Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. 70
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. 69
Extra-endoscopic mechanical lithotripsy of an impacted gallstone passing in the duodenum through a cholecystoduodenal fistula 69
Are we ready for early discharge of patients with mild non-alcoholic acute interstitial pancreatitis? 67
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 66
Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis. 66
Endoscopic Ultrasonography May Select Subjects Having Asymptomatic Chronic Pancreatic Hyperenzymemia Who Require a Stricter Follow-up 65
CCR1 and CCR5 promote hepatic fibrosis in mice. 64
Small bowel diverticulitis with severe anemia and abdominal pain 64
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 63
Fibrogenesis in nonalcoholic steatohepatitis. 62
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 62
Gene expression profiles during hepatic stellate cell activation in culture and in vivo. 59
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 59
Origin of myofibroblasts in liver fibrosis. 59
Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. 57
Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. 57
TLR4 enhances TGF-beta signaling and hepatic fibrosis. 55
Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma 55
CCR2 promotes hepatic fibrosis in mice 54
HEPATOPROTECTIVE AND ANTIFIBROTIC EFFECT OF A NEW SILYBIN-PHOSPHATIDYLCHOLINE-VITAMIN E COMPLEX IN RATS 53
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. 51
Investigating the role of the extracellular environment in modulating hepatic stellate cell biology with arrayed combinatorial microenvironments. 47
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. 47
The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. 44
Modulation of hepatic fibrosis by c-Jun-N-terminal kinase inhibition. 41
New insights in hepatocellular carcinoma: from bench to bedside 41
JNK1 From Hematopoietic Cells Mediates Progression From Hepatic Steatosis to Steatohepatitis and Fibrosis in Mice. 40
NADPH oxidase in the liver: defensive, offensive, or fibrogenic? 39
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase. 38
NOX in liver fibrosis. 36
Totale 2.808
Categoria #
all - tutte 14.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020264 1 0 44 1 44 0 44 0 44 2 13 71
2020/2021694 35 78 90 22 88 28 67 47 62 69 60 48
2021/2022331 18 82 7 9 3 24 14 15 22 50 21 66
2022/2023700 53 83 41 57 45 116 3 40 155 4 90 13
2023/2024360 66 4 27 60 50 71 5 5 5 7 3 57
2024/202555 55 0 0 0 0 0 0 0 0 0 0 0
Totale 2.808